These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y. Cancer Res; 1999 Jan 15; 59(2):467-73. PubMed ID: 9927064 [Abstract] [Full Text] [Related]
3. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y. J Pathol; 2004 Apr 15; 202(4):403-11. PubMed ID: 15095267 [Abstract] [Full Text] [Related]
4. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y. Am J Pathol; 1999 Feb 15; 154(2):417-28. PubMed ID: 10027400 [Abstract] [Full Text] [Related]
7. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T. Br J Cancer; 1998 Jun 15; 77(12):2239-45. PubMed ID: 9649139 [Abstract] [Full Text] [Related]
11. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A, Salamonsen LA. Cancer; 2002 Mar 01; 94(5):1466-75. PubMed ID: 11920503 [Abstract] [Full Text] [Related]
12. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Sato T, Iwai M, Sakai T, Sato H, Seiki M, Mori Y, Ito A. Br J Cancer; 1999 Jun 01; 80(8):1137-43. PubMed ID: 10376963 [Abstract] [Full Text] [Related]
13. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H, Okada Y. J Neurosurg; 2001 Mar 01; 94(3):464-73. PubMed ID: 11235952 [Abstract] [Full Text] [Related]
17. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. Shofuda K, Moriyama K, Nishihashi A, Higashi S, Mizushima H, Yasumitsu H, Miki K, Sato H, Seiki M, Miyazaki K. J Biochem; 1998 Aug 01; 124(2):462-70. PubMed ID: 9685743 [Abstract] [Full Text] [Related]
19. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H. Hum Pathol; 2000 Aug 01; 31(8):895-904. PubMed ID: 10987249 [Abstract] [Full Text] [Related]